| Age group | Total 45-69 | Total 50-69 | |||||
---|---|---|---|---|---|---|---|---|
 | 45-49 | 50-54 | 55-59 | 60-64 | 65-69 | 70-74 |  |  |
Number of women screened | 95,883 | 106,232 | 105,578 | 90,394 | 55,427 | 4,848 | 453,514 | 357,631 |
Estimate of 24 m coverage by examination | 58.0% | 55.0% | 51.6% | 47.5% | 42.3% | 14.5% | 51.2% | 49.6% |
   Number of women with detected breast cancer | 254 | 374 | 416 | 577 | 409 | 67 | 2,030 | 1,776 |
Breast cancer detection rate | 2.6 | 3.5 | 3.9 | 6.4 | 7.4 | 13.8 | 4.5 | 5.0 |
   Number of women undergoing further assessment | 20,881 | 14,923 | 10,318 | 7,174 | 3,959 | 409 | 57,255 | 36,374 |
Further assessment rate | 21.8% | 14.0% | 9.8% | 7.9% | 7.1% | 8.4% | 12.6% | 10.2% |
   Number of women recalled for further assessment | 3,652 | 2,913 | 2,421 | 2,149 | 1,291 | 162 | 12,426 | 8,774 |
Recall rate | 3.8% | 2.7% | 2.3% | 2.4% | 2.3% | 3.3% | 2.7% | 2.5% |
   Women undergoing open biopsy - benign result | 50 | 40 | 27 | 31 | 21 | 1 | 169 | 119 |
   Women undergoing open biopsy - malignant result | 211 | 315 | 368 | 481 | 334 | 58 | 1,709 | 1,498 |
Benign to malignant open biopsy ratio | 0.24 | 0.13 | 0.07 | 0.06 | 0.06 | 0.02 | 0.10 | 0.08 |
   Number of women with detected breast cancer (cases preceded by neoadjuvant therapy excluded) | 239 | 352 | 401 | 555 | 399 | 65 | 1,946 | 1,707 |
Advanced cases (TNM II+) | 63 | 98 | 104 | 131 | 95 | 27 | 491 | 428 |
Advanced cases proportion | 26.4% | 27.8% | 25.9% | 23.6% | 23.8% | 41.5% | 25.2% | 25.1% |
Invasive cases | 216 | 315 | 343 | 508 | 360 | 63 | 1,742 | 1,526 |
Invasive cases proportion | 90.4% | 89.5% | 85.5% | 91.5% | 90.2% | 96.9% | 89.5% | 89.4% |
Node-negative invasive cases | 131 | 196 | 238 | 342 | 255 | 38 | 1,162 | 1,031 |
Proportion among invasive | 60.6% | 62.2% | 69.4% | 67.3% | 70.8% | 60.3% | 66.7% | 67.6% |
Invasive ≤ 10 mm cases | 70 | 110 | 119 | 179 | 146 | 19 | 624 | 554 |
Proportion among invasive | 32.4% | 34.9% | 34.7% | 35.2% | 40.6% | 30.2% | 35.8% | 36.3% |